We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
The Mission Marketing Group Plc | LSE:TMMG | London | Ordinary Share | GB00B11FD453 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 78.50 | 77.00 | 80.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
23/3/2015 15:12 | Results tomorrow. Not many forecasts about. Just hope for a solid start to this year and a bright outlook. Date 18/3/15 FinnCap 18-03-15 Pretx £6.40m EPS 5.70p DPS 1.20p | dr biotech | |
06/3/2015 14:01 | trades now going through at over 42p but less than the full 43p offer. I see that the last trade was for a small amount of shares at the 41p bid. Perhaps we are still some way from the bid ticking up. Asagi (long TMMG) | asagi | |
05/3/2015 13:41 | To quote the article directly "The missions current share price rating suggests the market retains some worries over the companies long term health" I guess it depends on how you want to interpret that. I can't think of any other reason for the valuation. Perhaps the big difference between H1/H2 figures makes some feel uncomfortable. | dr biotech | |
05/3/2015 13:20 | DB - I can't agree with your opinion of the article. I doubt the author, David O'Hara, would either or why would he purchase shares in the Company. | busterdog2 | |
05/3/2015 10:08 | I would rather it flat lined at the top of the price range than at the bottom though. Results in a couple of weeks. Not sure they will shift the share price one way or another. I guess confirmation that H2 was good may be a positive. As the above article states there seems to be a lack of belief in this company, hence the relatively low valuation. | dr biotech | |
05/3/2015 09:02 | Always a good sign. | busterdog2 | |
04/3/2015 13:59 | Quiet, tedious, boring. | macarre | |
22/2/2015 23:22 | Sp must close above 41p before rise resumes. | macarre | |
12/2/2015 12:39 | I have absolutely no idea why this share is rated so low so I'm in for another 3800 quids worth at 40.40. Good luck all! | red_shed2000 | |
11/2/2015 22:01 | Close to bottom now. | macarre | |
03/2/2015 13:02 | The back of. Creston s announcement I expect. | deanowls | |
03/2/2015 11:55 | Not really sure why this is near its 12month low. IMS was good enough. Perhaps they need a decent PR company... | dr biotech | |
02/2/2015 19:26 | Quiet day. The 12,021 buy was mine. | macarre | |
27/1/2015 20:06 | Thanks Jeff have to admit I had missed that! | pj 1 | |
27/1/2015 20:04 | PJ1 - the various agencies are run autonomously....here their annual report:- "Unlike other groups, our Board is comprised of the entrepreneurs who run our Agencies. Talented people with a passion to make our Clients famous and successful. Whatever the discipline. And by being focused on their Agencies yet fully supportive of the group they deliver all the creativity of a boutique with the resource of a multi national." | jeff h | |
27/1/2015 11:01 | Any views on why they have 11 Directors? | pj 1 | |
27/1/2015 10:38 | I have been here a while - actually posted last week. Its actually my largest small cap holding. I am hoping its going to return the the 50-60 level. May take some time, but they seem to be doing OK. Avoiding nasty surprises is the issue. The IMS is just about identical to last years, just with different dates. I was hoping for something a bit substantial or even chatty, but after the CEO did that a few years ago it didn't go down well when things took a turn for the worse. | dr biotech | |
27/1/2015 10:00 | Glasshalfull - I'm in today. Thanks for highlighting. I think this is a good point to buy in as debt is being reduced so markedly. Nice point in the chart too. Spread a bit wide though. | dasv | |
27/1/2015 08:29 | Re: debt At the half-year there were warnings that the debt would be expected to increase in H2 viz "As in prior years, due to the phasing of working capital requirements, an increase in net debt is predicted in the second half of the year" Yesterdays RNS has trumped that with "We also expect our year-on-year net bank debt, gearing ratio and debt leverage ratio to be further reduced". Happy days | joe say | |
27/1/2015 08:21 | Been here for a short while GHF but as you like quiet threads I thought I would leave it like that :-) | cheshire man | |
27/1/2015 07:56 | Nice summary GHF. | jeff h | |
27/1/2015 07:29 | Having a good look GHF, disaster @ Flybe stopped me in my tracks yesterday! :-(( | pj 1 | |
27/1/2015 07:17 | Here also and very happy to hold. V low rating on business which should be late cycle. | 18bt |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions